Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines: Critical Reviews in Oncology/Hematology

F. Passiglia, S. Pilotto, F. Facchinetti, L. Bertolaccini, M. Del Re, R. Ferrara, T. Franchina, U. Malapelle, J. Menis, A. Passaro, S. Ramella, G. Rossi, R. Trisolini, S. Novello

Research output: Contribution to journalArticlepeer-review

Abstract

The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice. © 2019 Elsevier B.V.
Original languageEnglish
JournalCrit. Rev. Oncol. Hematol.
Volume146
DOIs
Publication statusPublished - 2020

Keywords

  • Clinical practice guidelines
  • Metastatic disease
  • Non-small cell lung cancer
  • Recommendations
  • afatinib
  • alectinib
  • antineoplastic metal complex
  • atezolizumab
  • bevacizumab
  • ceritinib
  • crizotinib
  • docetaxel
  • erlotinib
  • gefitinib
  • nintedanib
  • nivolumab
  • osimertinib
  • pembrolizumab
  • pemetrexed
  • antineoplastic agent
  • ALK gene
  • cancer chemotherapy
  • cancer growth
  • cancer immunotherapy
  • cancer patient
  • cancer therapy
  • EGFR gene
  • exon
  • follow up
  • gene insertion
  • gene mutation
  • gene rearrangement
  • human
  • maintenance therapy
  • non small cell lung cancer
  • oncogene
  • overall survival
  • practice guideline
  • progression free survival
  • Review
  • ROS1 gene
  • Italy
  • lung tumor
  • medical society
  • oncology
  • pathology
  • Antineoplastic Agents
  • Carcinoma, Non-Small-Cell Lung
  • Humans
  • Lung Neoplasms
  • Medical Oncology
  • Practice Guidelines as Topic
  • Societies, Medical

Fingerprint

Dive into the research topics of 'Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines: Critical Reviews in Oncology/Hematology'. Together they form a unique fingerprint.

Cite this